BERGEN-BRUNSWIG, McKESSON ARE BACK IN INVESTMENT FAVOR; CHAINS AND WHSLRS. FLOURISH IN FIRST QUARTER; RORER AND GENERICS STRONG AMONG MANUFACTURERS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".